• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

7 New Drugs Approved for Primary Care: Q1 2022

Slideshow

At the close of the first quarter of a new year, Patient Care Online has compiled a list of 7 new FDA-approved drugs for conditions that are often seen in primary care. Scroll through the slides below to find details on a new oral solution of amlodipine; the first and only FDA-approved, once-daily amphetamine transdermal patch for the treatment of attention deficit hyperactivity disorder; and 5 more.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
E-Cigarette Packaging to Resemble Products for Youth Prompt More FDA Warning Letters imaged credit US Food and Drug Administration

E-Cigarette Packaging to Resemble Products for Youth Prompt More FDA Warning Letters

December 5th 2023
Article

Camouflaging e-cigarettes as kid- and teen-appealing drinks and toys may help youth conceal the products from adults, increase risk of harm to children.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection image credit paxlovid ©Mike Mareen / stock.adobe.com

Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection

November 16th 2023
Article

The finding implies the potential for virus transmission after initial recovery from the infection, according to study authors.

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

October 25th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.

FDA Approves Vonoprazan for the Treatment of Erosive Esophagitis /image credit GERD ©Waldenmarus/Stock.adobe.com

Vonoprazan, Novel Treatment for Erosive Esophagitis, Gets FDA Nod

November 3rd 2023
Article

The novel potassium-competitive acid blocker is the first new treatment approved for the potentially cancer-producing GI disease in 30 years.

Remdesivir Linked to Lower Mortality in Patients with COVID-19 Requiring Supplemental Oxygen / Image credit: ©Tobias Arhelger/AdobeStock

Remdesivir Linked to Lower Mortality in Patients with COVID-19 Requiring Supplemental Oxygen

October 31st 2023
Article

Remdesivir use was associated with increased survival among patients hospitalized with COVID-19 requiring supplemental oxygen across SARS-CoV-2 variants of concern, report researchers.

© 2023 MJH Life Sciences

All rights reserved.